Ark Invest's third-quarter report highlighted Tempus AI as a standout performer. Tempus AI contributed 3.21 percentage points to the ARK Genomic Revolution ETF (ARKG). It added 2.08 points to the ARK Innovation ETF (ARKK). During the third quarter, Tempus AI's stock gained 41.38%.
This positive analysis followed a recent downturn in the company's stock. The stock fell on October 16. The drop was reportedly due to investor caution. This caution surrounded the announcement of its upcoming third-quarter earnings release date and an expanded collaboration with Merck.